Elevation Gross Profit from 2010 to 2024

ELEV Stock

USD 0.64 0.02 3.23%

Elevation Oncology Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit will likely drop to about -41 K in 2024. Gross Profit is the profit Elevation Oncology makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2010-12-31

Previous Quarter

-39 K

Current Value

-41 K

Quarterly Volatility

8.9 K

Credit Downgrade

Yuan Drop

Covid

Check Elevation Oncology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elevation Oncology's main balance sheet or income statement drivers, such as Depreciation And Amortization of 37 K, Interest Expense of 4.4 M or Selling General Administrative of 9.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.35. Elevation financial statements analysis is a perfect complement when working with Elevation Oncology Valuation or Volatility modules.

Check out the analysis of Elevation Oncology Correlation against competitors.

For more information on how to buy Elevation Stock please use our How to Invest in Elevation Oncology guide.

Latest Elevation Oncology's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Elevation Oncology over the last few years. Gross profit is a required income statement account that reflects total revenue of Elevation Oncology minus its cost of goods sold. It is profit before Elevation Oncology operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Elevation Oncology's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Elevation Oncology's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Elevation Gross Profit Regression Statistics

	Arithmetic Mean	(19,330)
	Coefficient Of Variation	(46.30)
	Mean Deviation	6,528
	Median	(15,000)
	Standard Deviation	8,949
	Sample Variance	80.1M
	Range	25.9K
	R-Value	(0.71)
	Mean Square Error	42.8M
	R-Squared	0.50
	Significance	0
	Slope	(1,420)
	Total Sum of Squares	1.1B

Elevation Gross Profit History

	2024	-41 K
	2023	-39 K
	2022	-27 K
	2021	-18 K

Other Fundumenentals of Elevation Oncology

Gross Profit Margin

Elevation Oncology Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt	Long Term Debt Total	Capital Surpluse
Total Assets		0.85	0.85	-0.8	-0.71	0.74	0.51	0.87	1.0	1.0	0.15	0.41	0.55	0.37	-0.42	-0.42
Total Stockholder Equity	0.85		1.0	-0.72	-0.58	0.5	-0.02	0.98	0.85	0.85	-0.03	0.34	0.43	0.27	-0.32	-0.32
Net Tangible Assets	0.85	1.0		-0.72	-0.58	0.5	-0.02	0.98	0.85	0.85	-0.04	0.34	0.43	0.25	-0.31	-0.31
Net Debt	-0.8	-0.72	-0.72		0.17	-0.74	-0.38	-0.63	-0.81	-0.82	0.34	0.0	0.02	0.0	0.0	0.0
Retained Earnings	-0.71	-0.58	-0.58	0.17		-0.26	-0.36	-0.72	-0.71	-0.7	-0.53	-0.79	-0.93	-0.68	0.78	0.78
Accounts Payable	0.74	0.5	0.5	-0.74	-0.26		0.64	0.51	0.75	0.72	0.28	-0.18	0.22	-0.16	0.18	0.18
Total Liab	0.51	-0.02	-0.02	-0.38	-0.36	0.64		0.06	0.51	0.5	0.32	0.19	0.33	0.16	-0.18	-0.18
Net Invested Capital	0.87	0.98	0.98	-0.63	-0.72	0.51	0.06		0.87	0.87	0.13	0.46	0.6	0.32	-0.4	-0.4
Total Current Assets	1.0	0.85	0.85	-0.81	-0.71	0.75	0.51	0.87		1.0	0.15	0.41	0.55	0.37	-0.42	-0.42
Net Working Capital	1.0	0.85	0.85	-0.82	-0.7	0.72	0.5	0.87	1.0		0.1	0.42	0.53	0.37	-0.43	-0.43
Intangible Assets	0.15	-0.03	-0.04	0.34	-0.53	0.28	0.32	0.13	0.15	0.1		0.11	0.64	0.23	-0.22	-0.22
Common Stock	0.41	0.34	0.34	0.0	-0.79	-0.18	0.19	0.46	0.41	0.42	0.11		0.78	0.55	-0.75	-0.75
Property Plant Equipment	0.55	0.43	0.43	0.02	-0.93	0.22	0.33	0.6	0.55	0.53	0.64	0.78		0.43	-0.59	-0.59
Long Term Debt	0.37	0.27	0.25	0.0	-0.68	-0.16	0.16	0.32	0.37	0.37	0.23	0.55	0.43		-0.96	-0.96
Long Term Debt Total	-0.42	-0.32	-0.31	0.0	0.78	0.18	-0.18	-0.4	-0.42	-0.43	-0.22	-0.75	-0.59	-0.96		1.0
Capital Surpluse	-0.42	-0.32	-0.31	0.0	0.78	0.18	-0.18	-0.4	-0.42	-0.43	-0.22	-0.75	-0.59	-0.96	1.0

Click cells to compare fundamentals

About Elevation Oncology Financial Statements

Elevation Oncology investors use historical fundamental indicators, such as Elevation Oncology's Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Elevation Oncology. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Gross Profit	-39 K	-41 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Elevation Stock Analysis

When running Elevation Oncology's price analysis, check to measure Elevation Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevation Oncology is operating at the current time. Most of Elevation Oncology's value examination focuses on studying past and present price action to predict the probability of Elevation Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevation Oncology's price. Additionally, you may evaluate how the addition of Elevation Oncology to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC